IRIS

IACOBELLI, Stefano

IACOBELLI, Stefano  

DIPARTIMENTO DI SCIENZE MEDICHE, ORALI E BIOTECNOLOGICHE  

Mostra records
Risultati 1 - 20 di 196 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
90K (Mac-2 BP) and galectins in tumor progression and metastasis. 2002 Grassadonia, Antonino; Tinari, Nicola; Iurisci, I; Piccolo, E; Cumashi, A; Innominato, P; D'Egidio, M; Natoli, Clara; Piantelli, Mauro; Iacobelli, Stefano
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells 1998 Fusco, Ornella; Querzoli, Patrizia; Nenci, Italo; Natoli, Clara; Brakebush, Cord; Ullrich, Axel; Iacobelli, Stefano
90K (Mac-2 BP) in human milk 1996 D'Ostilio, Nicola; Ullrich, Axel; Iacobelli, Stefano; Natoli, Clara; Sabatino, Giuseppe
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10^6 cells/L 1998 Tinari, N; Natoli, C; D'Ostilio, N; Ghinelli, F; Sighinolfi, L; Ortona, L; Tamburrini, E; Piazza, M; Chirianni, A; Guerra, L; Di Gregorio, P; Iacobelli, S
90k is a serum marker of poor-prognosis in non-hodgkins-lymphoma patients. 1994 Rea, A; Palmieri, G; Tinari, Nicola; Natoli, Clara; Tagliaferri, P; Morabito, A; Grassadonia, Antonino; Bianco, A; Iacobelli, Stefano
90K protein in HIV infection: evidence of its release from peripheral blood mononuclear cells 1995 D'Egidio, Maurizia; DI STEFANO, P; Tentarelli, R; Alterio, L; Amatetti, Cristina; Iacobelli, Stefano; Natoli, Clara
90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection. 1993 Natoli, Clara; Dianzani, F; Mazzotta, F; Balocchini, E; Pierotti, P; Antonelli, G; Iacobelli, Stefano
[Hairy cell leukemia: prognosis and treatment] 2006 Quaresima, M; Iacobelli, Stefano; Tempera, S; Frattarelli, N; Bizzoni, L; Anaclerico, B; Matturro, A; Cucchi, F; Tafuri, A; Pulsoni, A.
A 13-state homogeneous semi-Markov model for predicting the HIV disease evolution: a case study 2007 DI BIASE, Giuseppe; D'Amico, Guglielmo; DI GIROLAMO, A; Janssen, J; Iacobelli, Stefano; Tinari, Nicola; Manca, R.
A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men. 1993 Briggs, Nc; Natoli, Clara; Tinari, Nicola; D'Egidio, M; Goedert, Jj; Iacobelli, Stefano
A comparative study of the antiinflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds 2007 Cumashi, A; Ushakova, Na; Preobrazhenskaya, Me; D'Incecco, Alessandra; Piccoli, A; Totani, L; Tinari, Nicola; Morozevich, Ge; Berman, Ae; Bilan, Mi; Usov, Ai; Ustuzhanina, Ne; Sanderson, Cj; Kelly, M; Rabinovich, Ga; Iacobelli, Stefano; Nifantiev, Ne
A multicenter phase II study of epirubicin (E) with low-dose herceptin (LD-H) as a first-line treatment in HER2 overexpressing metastatic breast cancer (MBC) 2007 De Tursi, M; Carella, C; Ricevuto, E; Gennari, A; Orlandini, C; Frassoldati, A; Conte, Pf; Iacobelli, S
A multicenter phase II study of Epirubicin with low-dose Herceptin as a first line treatment in HER-2 overexpressing metastatic breast cancer 2007 DE TURSI, Michele; Carella, Consiglia; Ricevuto, E; Gennari, A; Orlandini, C; Frassoldati, A; Conte, Pf; Iacobelli, Stefano
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis. 1997 Gridelli, C; Ianniello, G; Ambrosini, G; Mustacchi, G; Pedicini, T; Farris, A; Iacobelli, Stefano; Rossi, G; Moretti, G; Angelini, F; Delena, M; Dicarlo, A; Bonsignori, M; Sabbatini, R; Catalano, G; Rossi, A; Olivieri, A; Fina, P; Bianco, A.
A phase I study of 5-day continuous venous infusion of carboplatin (CBDCA) at circadian rhythm-modulated rate 1996 Irtelli, Luciana; MARTINO MARIA, Teresa; Fiorentino, Bruno; Garufi, Carlo; Grassadonia, Antonino; Iacobelli, Stefano; Natoli, Clara
A phase I study of recombinant interferon-alpha administered as a seven-day continuous venous infusion at circadian-rhythm modulated rate in patients with cancer. 1995 Iacobelli, Stefano; Garufi, C; Irtelli, L; Martino, Mt; Santobuono, Fernanda; Vicario, G; Tinari, Nicola; Fiorentino, B; Innocenti, Paolo; Natoli, Clara
A phase II study of cisplatin, epirubicin, vindesine chemotherapy and lonidamine in advanced nonsmall cell lung cancer 1996 Irtelli, Luciana; MARTINO MARIA, Teresa; Iacobelli, Stefano; Natoli, Clara
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer. 2007 Natoli, Clara; Cianchetti, Ettore; Tinari, Nicola; Angelucci, D; Grassadonia, Antonino; Zilli, Marinella; Ficorella, C; Ricevuto, E; Grossi, Simona; DE TURSI, Michele; Carella, Consiglia; Rispoli, Ai; Iacobelli, Stefano
A PHASE II STUDY OF NEOADJUVANT CHEMOTHERAPY WITH CISTAPLIN, EPIRUBICIN AND VP – 16 FOR STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER 1998 Iacobelli, Stefano; L., Irtelli; Sacco, Rocco; T., Martino; Mascitelli, Elia; L., Basilico; M. T., Scognamiglio; Natoli, Clara; O., Fusco; Tinari, Nicola; V., Beltrami
A stochastic model for evaluating the HIV anti-retroviral treatment patient cost: a case study 2006 DI BIASE, Giuseppe; Di Girolamo, A.; Janssen, J.; Iacobelli, Stefano; Tinari, Nicola; Manca, R.